Utility of Plasma Biomarkers in Screening for Brain Amyloid in the 1Florida Alzheimer Disease Research Center (ADRC) Article

Barker, Warren W, Velasquez, Karen, Loewenstein, David A et al. (2024). Utility of Plasma Biomarkers in Screening for Brain Amyloid in the 1Florida Alzheimer Disease Research Center (ADRC) . ALZHEIMERS & DEMENTIA, 20(Suppl 2), e091578. 10.1002/alz.091578

cited authors

  • Barker, Warren W; Velasquez, Karen; Loewenstein, David A; Curiel, Rosie E; Armstrong, Melissa J; Rosselli, Monica; Adjouadi, Malek; Asken, Breton M; Vaillancourt, David; DeSimone, Jesse; Smith, Glenn E; Marsiske, Michael; Fiala, Jacob; Weber, Darren M; Kim, Jueun C; Herrera, Mileidys; Velez‐Uribe, Idaly; Duara, Ranjan

authors

publication date

  • December 1, 2024

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 4.1 Discovery and preclinical testing of markers and technologies
  • Acquired Cognitive Impairment
  • Aging
  • Alzheimer's Disease
  • Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
  • Biomedical Imaging
  • Brain Disorders
  • Clinical Research
  • Dementia
  • Minority Health
  • Neurodegenerative
  • Neurological
  • Neurosciences

Digital Object Identifier (DOI)

publisher

  • Wiley

start page

  • e091578

volume

  • 20

issue

  • Suppl 2